Eurofins Scientific: Director / PDMR Shareholding
07.08.2025 - 17:58:14This notification is made in accordance with the European Market Abuse Regulation.
NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM
Â
1.
Details of the person discharging managerial responsibilities/person closely associated
a)
Name
Analytical Bioventures S.C.A (RCS B89265)
23, Va Fleuri, L-1526 Luxembourg
2.
Reason for the notification
a)
Position / status
Analytical Bioventures S.C.A. is a company controlled by Eurofins Scientific S.E., CEO Dr. Gilles Martin
b)
Initial notification / amendment
Initial
3.
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)
Name
Eurofins Scientific S.E.
Â
b)
LEI
529900JEHFM47DYY3S57
Â
4.
Details of the transaction(s) section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument, type of instrument
Share
Â
Identification code
ISIN: FR0014000MR3
b)
Nature of the transaction
Acquisition of shares
Â
Â
c)
Price(s) and volume(s)
Price(s)
Volume(s)
EUR 59.7304
2000
d)
Aggregated information
Â
— Aggregated volume
2000
— Price
EUR 119,460.80
e)
Date of the transaction
2025-06-19
f)
Place of the transaction
XPAR
NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM
Â
1.
Details of the person discharging managerial responsibilities/person closely associated
a)
Name
Analytical Bioventures S.C.A (RCS B89265)
23, Va Fleuri, L-1526 Luxembourg
2.
Reason for the notification
a)
Position / status
Analytical Bioventures S.C.A. is a company controlled by Eurofins Scientific S.E., CEO Dr. Gilles Martin
b)
Initial notification / amendment
Initial
3.
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)
Name
Eurofins Scientific S.E.
Â
b)
LEI
529900JEHFM47DYY3S57
Â
4.
Details of the transaction(s) section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument, type of instrument
Share
Â
Identification code
ISIN: FR0014000MR3
b)
Nature of the transaction
Acquisition of shares
Â
Â
c)
Price(s) and volume(s)
Price(s)
Volume(s)
EUR 59.4081
2000
d)
Aggregated information
Â
— Aggregated volume
2000
— Price
EUR 118,816.20
e)
Date of the transaction
2025-06-20
f)
Place of the transaction
XPAR
NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM
Â
1.
Details of the person discharging managerial responsibilities/person closely associated
a)
Name
Analytical Bioventures S.C.A (RCS B89265)
23, Va Fleuri, L-1526 Luxembourg
2.
Reason for the notification
a)
Position / status
Analytical Bioventures S.C.A. is a company controlled by Eurofins Scientific S.E., CEO Dr. Gilles Martin
b)
Initial notification / amendment
Initial
3.
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)
Name
Eurofins Scientific S.E.
Â
b)
LEI
529900JEHFM47DYY3S57
Â
4.
Details of the transaction(s) section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument, type of instrument
Share
Â
Identification code
ISIN: FR0014000MR3
b)
Nature of the transaction
Acquisition of shares
Â
Â
c)
Price(s) and volume(s)
Price(s)
Volume(s)
EUR 59.3430
2000
d)
Aggregated information
Â
— Aggregated volume
2000
— Price
EUR 118,686.00
e)
Date of the transaction
2025-06-23
f)
Place of the transaction
XPAR
NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM
Â
1.
Details of the person discharging managerial responsibilities/person closely associated
a)
Name
Analytical Bioventures S.C.A (RCS B89265)
23, Va Fleuri, L-1526 Luxembourg
2.
Reason for the notification
a)
Position / status
Analytical Bioventures S.C.A. is a company controlled by Eurofins Scientific S.E., CEO Dr. Gilles Martin
b)
Initial notification / amendment
Initial
3.
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)
Name
Eurofins Scientific S.E.
Â
b)
LEI
529900JEHFM47DYY3S57
Â
4.
Details of the transaction(s) section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument, type of instrument
Share
Â
Identification code
ISIN: FR0014000MR3
b)
Nature of the transaction
Acquisition of shares
Â
Â
c)
Price(s) and volume(s)
Price(s)
Volume(s)
EUR 59.8980
1432
d)
Aggregated information
Â
— Aggregated volume
1432
— Price
EUR 85,773.94
e)
Date of the transaction
2025-06-24
f)
Place of the transaction
XPAR
About Eurofins – the global leader in bio-analysis
Eurofins is Testing for Life. With ca. 63,000 staff across a network of more than 950 laboratories in over 1,000 companies in 60 countries, Eurofins offers a portfolio of over 200,000 analytical methods.
Eurofins Scientific S.E. shares are listed on Euronext Paris Stock Exchange.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250625356298/en/
@ businesswire.com
Hol dir den Wissensvorsprung der Profis. Seit 2005 liefert der Börsenbrief trading-notes verlässliche Trading-Empfehlungen – dreimal die Woche, direkt in dein Postfach. 100% kostenlos. 100% Expertenwissen. Trage einfach deine E-Mail Adresse ein und verpasse ab heute keine Top-Chance mehr.
Jetzt anmelden.

